| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |